03:04 PM EST - Avivagen Inc. : Reported its audited financial results for the year ended October 31, 2017. The Company reported revenues of $255,660 and a comprehensive loss from continuing operations of $5,045,645. As at October 31, 2017, the Company reported total assets of $1,849,687, total liabilities of $1,680,901 and shareholders’ equity of $168,786. Avivagen Inc.
shares V.VIV are trading down $0.04 at $0.93.
